Company Analysis

AnaptysBio, Inc. (ANAB)

Nasdaq: ANAB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2006
Grade6.4
◀ Past 6.1● Present 6.3▶ Future 6.7
3 est.

Who runs AnaptysBio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Faga Daniel
President, CEO. First filing Nov 2021, latest Aug 7, 2026, 6 filings in all.
Officers reporting now
5
of 14 people with a filing in the last fifteen months
Directors reporting now
9
25 people on the record since 2017
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Faga DanielPresident, CEONov 2021Aug 7, 202613 · $2.8M
Lizzul Paul F.Chief Medical OfficerJul 2020Aug 7, 20264 · $500,000
Murphy Christopher M.Chief Financial OfficerMay 2026May 13, 2026none
Loumeau Eric JCHIEF LEGAL OFFICERAug 2018Feb 13, 202612 · $2.7M
Mulroy DennisCHIEF FINANCIAL OFFICERJul 2020Jan 9, 20266 · $1.5M
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Renton HollingsdirectorJan 2017Oct 2, 20261 · $200,000
Orwin John AdirectorSep 2023Sep 17, 2026none
Schmid John P.directorJan 2017Jun 17, 20263 · $1.2M
Hughes OwendirectorMay 2026May 13, 2026none
Gray SusannahdirectorApr 2026Apr 29, 2026none
Marquet MagdadirectorJan 2021Jan 16, 20262 · $500,000
Fenton Dennis MdirectorMar 2018Jan 8, 2026none
Jain RitadirectorApr 2023Jan 8, 2026none
Ware J. AnthonydirectorAug 2017Jan 8, 20261 · $200,000
Owners of more than 10% of a classsales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Anaptysbio, Inc10% ownerApr 2026Apr 22, 2026none
Earlier names on the record27, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ANAB · research, not advice